PDGFRβ and B-Raf allosteric inhibitor. Also inhibits c-Raf, FLT3 and KIT. Disrupts blood vessel formation in zebrafish embryos and inhibits angiogenesis in a mouse angiogenesis model. Inhibits growth of renal and pancreatic tumors in mice. Also arrests cells in prometaphase. Orally available.
|Storage||Store at -20°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
|Solvent||Max Conc. mg/mL||Max Conc. mM|
Preparing Stock Solutions
The following data is based on the product molecular weight 459.45. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||2.18 mL||10.88 mL||21.77 mL|
|5 mM||0.44 mL||2.18 mL||4.35 mL|
|10 mM||0.22 mL||1.09 mL||2.18 mL|
|50 mM||0.04 mL||0.22 mL||0.44 mL|
References are publications that support the products' biological activity.
Murphy et al (2010) Disruption of angiogenesis and tumor growth with an orally active drug that stabilizes the inactive state of PDGFRbeta/B-RAF. Proc.Natl.Acad.Sci.U.S.A. 107 4299 PMID: 0154271
Mielgo et al (2011) A MEK-independent role for CRAF in mitosis and tumor progression. Nat.Med. 17 PMID: 22081024
If you know of a relevant reference for KG 5, please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: KG 5, supplier, KG5, KIT, FLT3, B-Raf, C-Raf, PDGFRbeta, PDGFRB, β, inhibitors, inhibits, anticancers, angiogenesis, antiangiogenics, FLT3, PDGFR, Other, RTKs, Raf, Kinase, Antiangiogenics, Raf, Kinase, Tocris Bioscience
Citations for KG 5
Citations are publications that use Tocris products.
Currently there are no citations for KG 5. Do you know of a great paper that uses KG 5 from Tocris? If so please let us know.
KG 5 Reviews
Average Rating:(Based on 0 Reviews)